Heyman E et al. |
Intense exercise increases circulating endocannabinoid and BDNF levels in humans--possible implications for reward and depression. |
2012 |
Psychoneuroendocrinology |
pmid:22029953
|
Hill MN et al. |
Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress. |
2009 |
Psychoneuroendocrinology |
pmid:19394765
|
Gray JM et al. |
Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function. |
2016 |
Psychoneuroendocrinology |
pmid:26821211
|
Marco EM et al. |
Emotional, endocrine and brain anandamide response to social challenge in infant male rats. |
2013 |
Psychoneuroendocrinology |
pmid:23660109
|
Fride E and Mechoulam R |
Developmental aspects of anandamide: ontogeny of response and prenatal exposure. |
1996 |
Psychoneuroendocrinology |
pmid:8774060
|
Kaufmann I et al. |
Anandamide and neutrophil function in patients with fibromyalgia. |
2008 |
Psychoneuroendocrinology |
pmid:18395993
|
Hill MN et al. |
Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks. |
2013 |
Psychoneuroendocrinology |
pmid:24035186
|
Schindler CW et al. |
Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys. |
2016 |
Psychopharmacology (Berl.) |
pmid:26803499
|
Naidu PS et al. |
Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality. |
2007 |
Psychopharmacology (Berl.) |
pmid:17279376
|
Panlilio LV et al. |
Effects of fatty acid amide hydrolase (FAAH) inhibitors on working memory in rats. |
2016 |
Psychopharmacology (Berl.) |
pmid:26558620
|
Fernandez-Espejo E and Galan-Rodriguez B |
Sensorimotor gating in mice is disrupted after AM404, an anandamide reuptake and degradation inhibitor. |
2004 |
Psychopharmacology (Berl.) |
pmid:15088080
|
Mallet PE and Beninger RJ |
The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide. |
1998 |
Psychopharmacology (Berl.) |
pmid:9862397
|
Cassano T et al. |
Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice. |
2011 |
Psychopharmacology (Berl.) |
pmid:21042794
|
Higgs S et al. |
Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716. |
2003 |
Psychopharmacology (Berl.) |
pmid:12447606
|
Cross-Mellor SK et al. |
Effects of the FAAH inhibitor, URB597, and anandamide on lithium-induced taste reactivity responses: a measure of nausea in the rat. |
2007 |
Psychopharmacology (Berl.) |
pmid:17111174
|
Morera-Herreras T et al. |
Nigrostriatal denervation changes the effect of cannabinoids on subthalamic neuronal activity in rats. |
2011 |
Psychopharmacology (Berl.) |
pmid:20959968
|
Aliczki M et al. |
Involvement of 2-arachidonoylglycerol signaling in social challenge responding of male CD1 mice. |
2015 |
Psychopharmacology (Berl.) |
pmid:25547462
|
Mangieri RA et al. |
An endocannabinoid signal associated with desire for alcohol is suppressed in recently abstinent alcoholics. |
2009 |
Psychopharmacology (Berl.) |
pmid:19343330
|
Panlilio LV et al. |
Anandamide-induced behavioral disruption through a vanilloid-dependent mechanism in rats. |
2009 |
Psychopharmacology (Berl.) |
pmid:19015836
|
Schacht JP et al. |
Intermediate cannabis dependence phenotypes and the FAAH C385A variant: an exploratory analysis. |
2009 |
Psychopharmacology (Berl.) |
pmid:19002671
|